Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Hidradenitis suppurativa improves with antiandrogen therapy.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Finasteride works better for hair loss in patients 26 or younger.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.